What Westminster Pharmaceuticals does

Westminster Pharmaceuticals (operating commercially as WPRX) is a privately held B2B generic pharmaceutical distributor founded in 2012 and headquartered in Nashville, Tennessee, with a sales office in Tampa, Florida. The company distributes more than 100 generic pharmaceutical products across three categories (prescription drugs, over-the-counter medications, and dietary supplements) to retail and hospital pharmacies, wholesalers, distributors, and manufacturers across the United States. Named enterprise customers include Walgreens and Rite-Aid, and the company manages 180 Medicaid program contracts across all 50 states. Approximately 90 percent of products are manufactured domestically in the United States, which the company positions as a supply chain and quality differentiator against generic competitors reliant on offshore production.

The business operates a relationship-driven, sales-led go-to-market with named contacts for business development, sales, customer service, regulatory affairs, and pharmacovigilance. Underlying technology centers on SAP/ATTP serialization software for unit-level product tracking and DSCSA compliance (met ahead of the November 2024 stabilization deadline), supplemented by predictive analytics for demand forecasting. Fulfillment runs through Direct Customer Solutions (formerly R&S Solutions), a 230,000 sq ft third-party logistics facility in West Tennessee with robotic handling, refrigeration, and secured storage capabilities. The company does not sell directly to consumers and operates a quote-based B2B pricing model with no publicly disclosed pricing.

Westminster generates revenue from the margin between acquisition and sale prices on distributed generic pharmaceuticals (transaction-fee model), supplemented by manufacturer-side distribution partnerships. The company has executed strategic partnerships with OEP Pharma (single-source miglitol distribution) and the USF Taneja College of Pharmacy (industry scholarship), and was recognized with the USF Fast 56 Class of 2021 award and an EY Entrepreneur of the Year 2022 nomination for CEO Louis Sanchez. Under Sanchez's ownership since 2016, the company has reported an average of 400 percent year-over-year growth, operating with a small team of 11-50 employees.

Name

Westminster Pharmaceuticals

Legal name

Westminster Pharmaceuticals

Website

https://wprx.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Westminster Pharmaceuticals is a privately held US generic drug distributor (WPRX) serving retail and hospital pharmacies, wholesalers, and manufacturers with 100-plus prescription, OTC, and dietary supplement products.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Generic pharmaceutical distribution
• Pharmaceutical wholesale supply
• Generic drug wholesale
• Pharmaceutical logistics services
• Generic medications supplier

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Generic Pharmaceutical Distribution: Westminster Pharmaceuticals generates revenue by distributing generic drugs to pharmacies, hospitals, and trusted wholesalers and distributors. The company acquires high-quality generic drugs within high-demand categories and distributes them through its partner network, with revenue derived from the margin between acquisition and sale prices to B2B customers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Westminster Pharmaceuticals distributes generic pharmaceutical products to retail pharmacies, hospital pharmacies, and authorized wholesalers and distributors across the United States. Its product portfolio spans prescription generic drugs (cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC products, and dietary supplements. Distribution and supply-chain operations are supported by a preferred 3PL partner and SAP/ATTP serialization technology for DSCSA-compliant traceability.

Product overview

Westminster Pharmaceuticals (WPRX) is a generic pharmaceutical distributor providing timely access to high-quality generic drugs at affordable prices. The company's product portfolio consists of three main categories distributed through pharmacies, hospitals, and wholesalers: Prescription Generic Drugs (including extended-release formulations, injectables, and oral solutions across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC Products (including analgesics, cold/cough medications, dermatological products, dental care products, and mineral supplements), and Dietary Supplements (including prenatal vitamins, iron supplements, and phosphorus supplements for dialysis patients). The portfolio includes branded product lines such as WesTussin cough liquids, WesTab/WesCaps/WesGel/WesNate prenatal supplements, and Wes-Phos phosphorus supplements. Nearly 90% of products are manufactured in the United States.

Differentiator

Problem solved

Functional benefit

Brands

• WPRX: Primary commercial brand name and website domain for Westminster Pharmaceuticals generic pharmaceutical distribution.

Products and services

• Prescription Generic Drugs Generic prescription pharmaceuticals distributed to retail and hospital pharmacies, encompassing more than 60 SKUs across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories, in forms including tablets, extended-release tablets, capsules, injectables, and oral solutions.
• OTC (Over-the-Counter) Products Over-the-counter generic pharmaceutical products distributed to pharmacies, including analgesics, cold and cough medications, dermatological products, dental care products, and mineral supplements.
• Dietary Supplements Nutritional and dietary supplements distributed through pharmacies, including prenatal vitamins (WesTab, WesCaps, WesGel DHA, WesNate DHA, PNV 27), iron supplements (Ferrous Fumarate, Ferrous Gluconate, Ferrous Sulfate, Iron Folate Plus, Iron Polysaccharide Complex), phosphorus supplements (Wes-Phos 250 Neutral), and other vitamin and mineral supplements.
• Miglitol Tablets Single-source generic anti-diabetic medication (alpha-glucosidase inhibitor) for type 2 diabetes control, distributed in North America under partnership with OEP Pharma (US subsidiary of Orient Europharma Co., Ltd).

Quantifiable outcome

• 400% average annual growth since 2016 new ownership
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor and core.

• University of South Florida Taneja College of PharmacyminorStrategic or Co-development Partner · 11 May 2021Westminster Pharmaceuticals Scholarship established to help pharmacy students pursue education. Scholarship awarded to graduate students including Md Sakil Amin (Pharmaceutical Nanotechnology) and Yevgeny Habibe (first recipient Spring 2023).
• R&S Solutions (now Direct Customer Solutions)coreChannel Partner/ Reseller/ Distributor · 3 March 2021Preferred third-party logistics (3PL) provider for warehousing, distribution, and fulfillment. R&S Solutions operates a 230,000-square-foot state-of-the-art facility in West Tennessee with access to major freight routes and commercial airports. Partnership ensures on-time fulfillment with 100% accuracy.
• OEP PharmacoreChannel Partner/ Reseller/ Distributor · 14 December 2020Partnership to distribute single-source generic drug miglitol. OEP Pharma (US subsidiary of Orient Europharma Co., Ltd) holds the only currently approved ANDA to miglitol and manufactures the product in Taiwan. Westminster oversees marketing and distribution in North America, enhancing patient access to the anti-diabetic medication.
• Direct Customer Solutions (formerly R&S Solutions)coreChannel Partner/ Reseller/ DistributorState-of-the-art fulfillment and distribution center featuring robotic technology, refrigeration capabilities, and enhanced security vault. Provides care, safety, and consistency for all products throughout the supply chain while preventing tampering.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• McKesson Corporation: Largest US pharmaceutical distributor, offering broad distribution, specialty, and biopharma services to pharmacies, hospitals, and manufacturers. Relevant as the dominant incumbent whose scale and reach Westminster competes against in the same customer segments.
• Cardinal Health: Major US pharmaceutical and medical products distributor with both wholesale and at-Home Solutions businesses. Comparable to Westminster as a Big 3 wholesaler competing for the same retail and hospital pharmacy customers.
• Cencora (formerly AmerisourceBergen): Top-3 US pharmaceutical wholesaler serving retail, hospital, and manufacturer clients with global distribution and consulting services. Directly comparable as one of the Big 3 incumbents whose services overlap with Westminster's generic distribution offering.

Direct peers

• Anda, Inc. Generic pharmaceutical distributor (a Teva subsidiary) supplying retail, hospital, and alternate-care customers in the US. Comparable to Westminster as a generic-led distributor that competes in the same mid-tier and specialty channels.
• Masters Pharmaceutical: Specialty and generic pharmaceutical distributor serving independent and mid-chain pharmacies, hospitals, and clinics. Comparable to Westminster as a smaller competitor specializing in generic and specialty distribution to non-Big-3 channels.
• Morris & Dickson Co. Privately held, family-owned US pharmaceutical wholesaler specializing in branded, generic, and specialty distribution to independent and regional pharmacies. Closest comparable to Westminster in scale, customer type, and product mix (generic-led portfolio serving mid-market pharmacies).
• Rochester Drug Cooperative: Independent, member-owned pharmaceutical wholesaler serving independent pharmacies across the Northeast and nationally. Comparable to Westminster as a mid-sized generic and brand distributor focused on independent and community pharmacy customers.
• Smith Drug Company: Regional pharmaceutical distributor serving independent pharmacies, hospitals, and long-term care facilities across the US. Comparable to Westminster as a mid-tier wholesaler competing on service quality and generics assortment against the Big 3.
• Quality King Distributors: US pharmaceutical distributor and supply-chain services company focused on generics, OTC, and health-and-beauty products to retailers and wholesalers. Comparable to Westminster as an independent mid-market distributor with a multi-category generic and OTC portfolio.

Others

• Direct Customer Solutions (R&S Solutions): Third-party logistics provider operating the 230,000 sq ft facility used by Westminster for warehousing and fulfillment. Relevant as Westminster's exclusive 3PL partner and as an ecosystem participant in the same pharmaceutical supply chain.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/WestminsterRX

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Westminster Pharmaceuticals